investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

PI 3-Kinase Signaling Pathways in Disease

David L Woodland

4 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Phillip T Hawkins

Babraham Institute (BBSRC)

Cambridge, United Kingdom

Lori Friedman

Genetech, Inc.

San Francisco, United States

Related projects

Mary Mcbride

Phase-Specific and Lifetime Medical Costs of Care for Childhood Cancer in British Columbia and Ontario

All cancers but non-melanoma skin cancer

Pediatric oncology or childhood cancer

Lingyin Li

A chemical biology approach towards understanding the anti-cancer innate immunity

All cancers but non-melanoma skin cancer

Alfred Singer

MHC-independent T cells

All cancers but non-melanoma skin cancer

Joel R Neilson

Translational control of EMT by the CELF1 RNA Binding Protein

All cancers but non-melanoma skin cancer

Peter S. Choi

Defining the role of RBM10 in RNA processing and tumor suppression

All cancers but non-melanoma skin cancer

Larry Keefer

Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies

All cancers but non-melanoma skin cancer

Pathology

Martin Allday

Epigenetic reprogramming of B cells in viral persistence, disease pathogenesis and tumour immunosurveillance.

All cancers but non-melanoma skin cancer

Barth Demian Grant

Endocytosis and Recycling in C. elegans and Mammals

All cancers but non-melanoma skin cancer

Robert S. Dipaola

Cancer Institute of New Jersey - Cancer Center Support Grant

All cancers but non-melanoma skin cancer